Table 5.
Fold of Cmax | Test system | Mitotoxicity | DILI+ | DILI− | PPV | NPV | Sensitivity | Specificity |
---|---|---|---|---|---|---|---|---|
100 | Intact-mito (excluded 3 drugs) | + | 10 | 5 | 67% | 31% | 53% | 44% |
− | 9 | 4 | ||||||
Intact and Sub-mito (excluded 1 drug) | + | 13 | 5 | 72% | 33% | 62% | 44% | |
− | 8 | 4 | ||||||
1 | Intact-mito | + | 3 | 0 | 100% | 32% | 14% | 100% |
− | 19 | 9 | ||||||
Intact and Sub-mito | + | 3 | 0 | 100% | 32% | 14% | 100% | |
− | 19 | 9 |
PPV positive predictive value, NPV negative predictive value, DILI drug-induced liver injury. A drug is considered as mitotoxicity positive (+) if it causes at least one type of mitochondrial injury. Intact-mito: data from whole mitochondria; Sub-mito: data from submitochondrial particles